PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
24.26%
Some net income increase while MCHP is negative at -5.68%. John Neff would see a short-term edge over the struggling competitor.
-2.07%
Negative yoy D&A while MCHP is 7.13%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-111.86%
Negative yoy deferred tax while MCHP stands at 234.58%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-26.32%
Both cut yoy SBC, with MCHP at -26.32%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
4400.00%
Well above MCHP's 269.65% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
-28.95%
AR is negative yoy while MCHP is 321.69%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
195.77%
Inventory growth well above MCHP's 104.03%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
-76.92%
Negative yoy AP while MCHP is 72.71%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
155.26%
Some yoy usage while MCHP is negative at -472.11%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-72.00%
Negative yoy while MCHP is 26.04%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
32.18%
Operating cash flow growth at 75-90% of MCHP's 40.42%. Bill Ackman would recommend further refinements to match competitor’s CFO gains.
12.03%
Lower CapEx growth vs. MCHP's 40.32%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
-12.03%
Negative yoy acquisition while MCHP stands at 100.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
1.51%
Less growth in investment purchases vs. MCHP's 20.46%, preserving near-term liquidity. David Dodd would confirm no strategic investment opportunities are lost.
-57.44%
We reduce yoy sales while MCHP is 9.77%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
7.89%
We have some outflow growth while MCHP is negative at -19.21%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-1027.69%
We reduce yoy invests while MCHP stands at 90.03%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
100.00%
We repay more while MCHP is negative at -375.46%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
-20.21%
Negative yoy issuance while MCHP is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
5.12%
Buyback growth below 50% of MCHP's 98.36%. Michael Burry suspects fewer capital returns to shareholders vs. competitor, unless expansions hold higher ROI.